Characteristics of homologous recombination repair pathway genes mutation in ovarian cancers
Abstract Background Few studies have investigated the characteristics of non‐BRCA homologous recombination repair (HRR) pathway somatic mutations, and the impact of these mutations on efficacy of treatment in ovarian cancer patients is not clear. Therefore, we conducted this study to analyze the fre...
Main Authors: | Zongbi Yi, Min Chen, Shaoxing Sun, Chunxu Yang, Zijie Mei, Hui Yang, Qingming Xiang, Hui Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | Cancer Innovation |
Subjects: | |
Online Access: | https://doi.org/10.1002/cai2.27 |
Similar Items
-
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma
by: Zheng Feng, et al.
Published: (2023-03-01) -
Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer
by: Yaolin Song, et al.
Published: (2024-01-01) -
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival
by: Tao Xie, et al.
Published: (2022-09-01) -
Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
by: Alexander M. A. van der Wiel, et al.
Published: (2022-08-01) -
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
by: A. W. Adamson, et al.
Published: (2023-07-01)